Steroid Refractory Acute Graft Versus Host Disease clinical trials

Explore recruiting steroid refractory acute graft versus host disease clinical trials.

Recruiting steroid refractory acute graft versus host disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Steroid Refractory Acute Graft Versus Host Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomised, Open label, Controlled, Multicentre, Phase 2 Trial of First line Treatment with Mesenchymal Stromal Cells MC0518 Versus Best Available Therapy in Paediatric Participants with Steroid refractory Acute Graft versus host Disease After Allogeneic Stem Cell Transplantation (BALDER Trial)

France, Spain, Germany, Poland, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomised, Open label, Multicentre, Phase 3 Trial of First line Treatment with Mesenchymal Stromal Cells MC0518 Versus Best Available Therapy in Adult and Adolescent Subjects with Steroid refractory Acute Graft versus host Disease After Allogeneic Haematopoietic Stem Cell Transplantation (IDUNN Trial)

Poland, Spain, France, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase 2 Open Label Prospective Dose-Ranging Clinical Trial with Escalation and Expansion Cohorts to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Dosing, and Efficacy of RLS-0071 for the Treatment of Hospitalized Patients with Steroid -Refractory Acute Graft-versus-Host Disease

Germany, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase 2 Open Label Prospective Dose-Ranging Clinical Trial with Escalation and Expansion Cohorts to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Dosing, and Efficacy of RLS-0071 for the Treatment of Hospitalized Patients with Steroid -Refractory Acute Graft-versus-Host Disease

Germany, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Steroid Refractory Acute Graft Versus Host Disease trials by city

Steroid Refractory Acute Graft Versus Host Disease in Toronto Steroid Refractory Acute Graft Versus Host Disease in Vancouver Steroid Refractory Acute Graft Versus Host Disease in Montreal Steroid Refractory Acute Graft Versus Host Disease in Calgary Steroid Refractory Acute Graft Versus Host Disease in Edmonton Steroid Refractory Acute Graft Versus Host Disease in Ottawa Steroid Refractory Acute Graft Versus Host Disease in Winnipeg Steroid Refractory Acute Graft Versus Host Disease in Quebec City Steroid Refractory Acute Graft Versus Host Disease in Hamilton Steroid Refractory Acute Graft Versus Host Disease in Kitchener Steroid Refractory Acute Graft Versus Host Disease in London Steroid Refractory Acute Graft Versus Host Disease in Halifax Steroid Refractory Acute Graft Versus Host Disease in New York Steroid Refractory Acute Graft Versus Host Disease in Los Angeles Steroid Refractory Acute Graft Versus Host Disease in Chicago Steroid Refractory Acute Graft Versus Host Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease